In CD1 included also Pranlukast, an agent used against ashma and allergy that exerts anti-inflammatory effects because it inhibits CysLT1 receptor, nuclear factor kappa B (NFƙB) and TNFα, suggesting a possible suppressive effect on the spinal cord inflammation and neutrophil infiltration [38]. The gene discussed is TNF; the disease is allergic disease.